The Journal of Organic Chemistry
Article
12.5 Hz), 4.54 (d, 1H, J = 5.5 Hz), 4.51 (d, 1H, J = 7.0 Hz), 4.42−4.40
(m, 3H), 4.35 (d, 1H, J = 8.0 Hz), 4.21 (m, 1H), 4.16 (dt, 1H, J = 2.0,
6.0 Hz), 3.98−3.93 (m, 2H), 3.91−3.68 (m, 8H), 3.57 (t, 1H, J = 7.0
Hz), 3.47 (m, 1H), 3.48 (dd, 1H, J = 7.0, 14.0 Hz), 2.71 (br s, 1H).
13C NMR (100 MHz, C6D6): δ 144.64, 139.7, 139.3, 139.2, 139.1,
139.0, 128.6, 128.5, 128.5, 128.3, 128.1, 127.9, 127.8, 127.6, 104.6,
103.8, 100.4, 85.2, 84.9, 82.6, 78.4, 76.8, 75.7, 75.6, 75.4, 75.1, 75.0,
74.9, 73.6, 73.6, 70.4. IR (thin film): 2920, 1645, 1506, 1459, 1345,
1063, 733, 700 cm−1. [α]D25 = +13.4° (c 0.5, CH2Cl2). HRESI−MS: m/
z calcd for C74H78O14Na [M + Na]+, 1213.5289; found, 1213.5292.
described in the general procedure. After workup, the crude mixture
was passed through a plug of silica gel (neutralized with 1% Et3N)
packed on a fritted funnel and eluted with 2% EtOAc in toluene with
1% Et3N to remove byproducts followed by EtOAc with 1% Et3N to
collect the product mixture. The residue was repurified by silica gel
chromatography using a 0−30% EtOAc−hexanes gradient with 1%
Et3N to afford the desired β,β,β-1,6-linked tetrasaccharide 28 as a
white solid (68 mg, 49%) and β,β,α-1,6-linked tetrasaccharide 28′ as a
1
minor product (14 mg, 10%). Major β,β,β-isomer 28: H NMR (500
MHz, C6D6): δ 7.60−6.91 (m, 55H), 6.28 (d, 1H, J = 5.9 Hz), 5.18−
5.03 (m, 4H), 5.00 (dd, 2H, J = 3.8, 11.3 Hz), 4.90−4.75 (m, 6H),
4.76−4.66 (m, 2H), 4.63−4.20 (m, 14H), 4.14 (d, 1H, J = 6.6 Hz),
4.05 (m, 1H), 3.93 (t, 1H, J = 7.5 Hz), 3.90−3.50 (m, 16H), 3.43−
3.37 (m, 2H), 1.04 (t, 1H, J = 7.1 Hz). 13C NMR (125 MHz, C6D6) δ
144.7, 139.7, 139.5, 139.4, 139.3, 139.3, 139.2, 139.0, 128.7, 128.6,
18.6, 128.6, 128.5, 128.4, 128.3, 128.1, 128.0, 127.9, 127.9, 127.7,
127.7, 127.6, 104.7, 103.7, 100.4, 85.2, 85.2, 84.9, 82.8, 82.7, 78.7, 78.4,
78.1, 76.9, 76.0, 75.6, 75.5, 75.4, 75.3, 75.1, 75.1, 75.0, 74.9, 74.8, 73.7,
73.6, 70.5, 69.5, 69.2, 68.9, 68.4. IR (thin film): 2924, 1717, 1464,
1274, 1058, 809, 738, 695 cm−1. [α]D25 = +5.8° (c 0.6, CH2Cl2). ESI−
MS: m/z for C101H106O19Na [M + Na]+, 1646.60. Minor β,β,α-isomer
28′: 1H NMR (500 MHz, C6D6): δ 7.67−6.81 (m, 55H), 6.21 (d, 1H,
J = 6.0 Hz), 5.12 (t, 2H, J = 10.7 Hz), 5.01 (d, 2H, J = 11.2 Hz), 4.96
(d, 2H, J = 10.3 Hz), 4.91 (d, 1H, J = 3.6 Hz), 4.90−4.71 (m, 7H),
4.71−4.61 (m, 3H), 4.60−4.45 (m, 4H), 4.43 (d, 2H, J = 11.8 Hz),
4.39−4.24 (m, 3H), 4.13 (m, 1H), 4.11−4.03 (m, 2H), 3.98−3.89 (m,
3H), 3.86−3.82 (m, 3H), 3.79−3.58 (m, 12H), 3.48 (ddd, 1H, J = 2.0,
5.6, 9.6 Hz), 3.38 (dt, 1H, J = 9.9, 3.1 Hz), 2.15 (d, 1H, J = 9.2 Hz).
13C NMR (125 MHz, C6D6): δ 144.7, 139.7, 139.6, 139.5, 139.5,
139.4, 139.3, 139.0, 128.7, 128.7, 128.6, 128.6, 128.5, 128.4, 128.3,
128.1, 128.0, 127.9, 127.7, 127.6, 104.8, 104.3, 100.4, 99.7, 85.2, 85.2,
83.7, 82.7, 82.7, 78.6, 78.3, 78.1, 76.6, 76.1, 75.6, 75.4, 75.3, 75.0, 74.9,
74.8, 74.7, 73.9, 73.6, 71.4, 70.4, 69.4, 69.0, 66.7. IR (thin film): 2898,
1
Minor β,α-isomer 25′: H NMR (500 MHz, C6D6): δ 7.50−7.04 (m,
40H), 6.21 (d, 1H, J = 8.5 Hz), 5.12 (d, 1H, J = 11.5 Hz), 4.98 (dd,
2H, J = 9.0, 10.0 Hz), 4.89−4.72 (m, 7H), 4.70 (dd, 1H, J = 2.5, 6.0
Hz), 4.64−4.61 (t, 2H, J = 9.5 Hz), 4.56 (d, 1H, J = 11.5 Hz), 4.48 (d,
1H, J = 12.0 Hz), 4.44−4.40 (m, 3H), 4.33 (d, 1H, J = 9.5 Hz), 4.28
(d, 1H, J = 11.5 Hz), 4.12 (dd, 2H, J = 3.0, 8.0 Hz), 4.06 (dd, 1H, J =
5.0, 11.0 Hz), 3.96 (m, 1H), 3.94−3.87 (m, 2H), 3.82 (dt, 1H, J = 4.0,
9.5 Hz), 3.73−3.65 (m, 7H), 3.60 (t, 1H, J = 8.5 Hz), 3.35 (dt, 1H, J =
2.5, 9.5 Hz), 2.05 (d, 1H, J = 9.5 Hz). 13C NMR (125 MHz, C6D6): δ
144.7, 139.6, 139.5, 139.3, 139.1, 139.0, 129.2, 128.7, 128.5, 128.3,
128.1, 127.8, 109.5, 104.5, 85.2, 82.6, 78.4, 78.2, 75.6, 74.9, 74.7, 74.1,
73.6, 71.3, 71.1, 70.4, 69.4, 69.0, 30.2. IR (thin film): 3966, 2911, 1648,
1498, 1458, 1362, 1081, 1027, 741, 704 cm−1. [α]D25 = +23.0° (c 0.8,
CH2Cl2). HRESI−MS: m/z calcd for C74H78O14Na [M + Na]+,
1213.5289; found, 1213.5321. Trisaccharide glycal 25 was also
1
characterized as the 2′-O-acetate; H NMR and pfg-COSY confirmed
the β configuration (J1′,2′ = 8.2 Hz).
2,3,4,6-Tetra-O-benzyl-β-D-glucopyranosyl-(1→6)-2-O-ace-
tyl-3,4-di-O-benzyl-β-D-glucopyranosyl-(1→6)-3,4-di-O-benzyl-
1
D-glucal (2′-O-acetyl 25). H NMR (400 MHz, CDCl3): δ 7.65−
6.78 (m, 40H), 6.28 (d, 1H, J = 6.2 Hz), 5.50 (t, 1H, J = 8.2 Hz), 5.04
(t, 1H, J = 11.6 Hz), 4.92−4.58 (m, 15H), 4.55 (d, 1H, J = 12.0 Hz),
4.46 (d, 1H, J = 12.2 Hz), 4.39 (d, 1H, J = 7.8 Hz), 4.31 (d, 1H, J =
12.2 Hz), 4.26 (d, 1H, J = 11.3 Hz), 4.01−4.07 (m, 2H), 3.91−3.87
(m, 2H), 3.81−3.74 (m, 5H), 3.64−3.54 (m, 3H), 3.53−3.45 (m, 2H),
1.72 (s, 3H).
1746, 1497, 1451, 1362, 1236, 1101, 1046, 742, 683 cm−1. [α]D25
=
+8.9° (c 1.3, CH2Cl2). ESI−MS: m/z for C101H106O19Na [M + Na]+,
1647. Tetrasaccharide glycals 28 and 28′ were also characterized as 2′-
1
2,3,4,6-Tetra-O-benzyl-β-D-glucopyranosyl-(1→6)-2,3,4-tri-
O-benzyl-β-D-glucopyranosyl-(1→6)-3,4-di-O-benzyl-D-glucal
(26). Trisaccharide glucal 25 (186 mg, 0.16 mmol) and TBAI (12 mg,
0.03 mmol) were dissolved in DMF (1.6 mL), cooled to 0 °C under
argon, and then treated with BnBr (38 μL, 0.32 mmol) and a 60%
dispersion of NaH in mineral oil (13 mg, 0.31 mmol). The ice bath
was removed, and the reaction mixture was stirred at rt for 12 h,
quenched at 0 °C with saturated NH4Cl (3 mL), and extracted with
Et2O (3 × 5 mL). The combined organic extracts were washed with
H2O (3 × 10 mL) and brine (5 mL), dried over Na2SO4, and
concentrated under reduced pressure. The resulting foamy solid was
recrystallized with Et2O in hexanes to afford benzyl ether 26 as white
O-acetates; H NMR and pfg-COSY confirmed the β configuration of
28 (J1′,2′ = 9.5 Hz) and the α configuration of 28′ (J1′,2′ = 3.6 Hz).
2,3,4,6-Tetra-O-benzyl-β-D-glucopyranosyl-(1→6)-2,3,4-tri-
O-benzyl-β-D-glucopyranosyl-(1→6)-2-O-acetyl-3,4-di-O-ben-
zyl-β-D-glucopyranosyl-(1→6)-3,4-di-O-benzyl-D-glucal (2-O-
1
acetyl 28). H NMR (500 MHz, C6D6): δ 7.73−6.64 (m, 55H),
6.38 (dd, 1H, J = 1.4, 6.2 Hz), 5.56 (dd, 1H, J = 8.0, 9.5 Hz), 5.31−
5.01 (m, 3H), 5.01−4.83 (m, 8H), 4.83−4.30 (m, 18H), 4.21−4.16
(m, 2H), 4.05−3.62 (m, 14H), 3.63−3.40 (m, 3H), 1.80 (s, 3H).
2,3,4,6-Tetra-O-benzyl-β-D-glucopyranosyl-(1→6)-2,3,4-tri-
O-benzyl-β-D-glucopyranosyl-(1→6)-2-O-acetyl-3,4-di-O-ben-
zyl-α-D-glucopyranosyl-(1→6)-3,4-di-O-benzyl-D-glucal (2-O-
1
1
acetyl 28′). H NMR (500 MHz, C6D6): δ 7.52−6.96 (m, 55H),
crystals (184 mg, 92% yield). H NMR (500 MHz, C6D6): δ 7.45−
6.14 (dd, 1H, J = 1.3, 6.1 Hz), 5.49 (d, 1H, J = 3.6 Hz), 5.23 (dd, 1H, J
= 3.5, 10.1 Hz), 5.13 (d, 2H, J = 11.4 Hz), 5.01 (d, 2H, J = 11.2 Hz),
4.92 (d, 1H, J = 11.6 Hz), 4.89−4.71 (m, 12H), 4.69−4.23 (m, 15H),
4.18 (ddd, 1H, J = 1.8, 5.1, 10.1 Hz), 4.10 (dt, 1H, J = 6.6, 1.8 Hz),
4.06−3.95 (m, 2H), 3.86 (dd, 1H, J = 5.9, 11.4 Hz), 3.83−3.58 (m,
16H), 3.54 (ddd, 1H, J = 1.9, 5.9, 9.7 Hz), 3.39 (dt, 1H, J = 9.8, 3.2
Hz), 1.80 (s, 3H).
7.06 (m, 45H), 6.31 (d, 1H, J = 6.0 Hz), 5.17 (d, 1H, J = 11.0 Hz),
5.12 (d, 1H, J = 11.0 Hz), 5.00 (d, 2H, J = 11.5 Hz), 4.87−4.77 (m,
6H), 4.74 (d, 1H, J = 5.0 Hz), 4.67 (d, 1H, J = 12.0 Hz), 4.61−4.54
(m, 4H), 4.50 (d, 1H, J = 12.0 Hz), 4.45−4.38 (m, 4H), 4.33 (d, 1H, J
= 11.5 Hz), 4.29 (d, 1H, J = 12.0 Hz), 4.13 (m, 1H), 4.09 (br s, 1H),
3.93 (dd, 1H, J = 5.5, 11.0 Hz), 3.89 (t, 1H, J = 7.0 Hz), 3.80 (dd, 1H,
J = 6.0, 11.0 Hz), 3.75−3.59 (m, 8H), 3.46 (m, 1H), 3.40 (m, 1H). 13C
NMR (125 MHz, C6D6): δ 144.8, 139.6, 139.5, 139.4, 139.3, 139.2,
139.0, 128.6, 128.5, 128.4, 128.3, 128.1, 128.0, 127.9, 127.7, 104.6,
104.3, 100.2, 85.2, 85.1, 82.7, 78.6, 78.4, 76.8, 75.6, 75.5, 75.3, 75.1,
74.9, 74.8, 73.6, 73.4, 70.3, 69.5, 68.9, 68.4. IR (thin film): 2915, 1510,
1451, 1366, 1075, 733, 695 cm−1. [α]D25 = +18.0° (c 2.0, CH2Cl2).
ESI−MS: m/z for C81H84O14Na [M + Na]+, 1304.07.
2,3,4,6-Tetra-O-benzyl-β-D-glucopyranosyl-(1→6)-2,3,4-tri-
O-benzyl-β-D-glucopyranosyl-(1→6)-3,4-di-O-benzyl-β-D-glu-
copyranosyl-(1→6)-3,4-di-O-benzyl-D-glucal (28). Trisaccharide
glycal 26 (111 mg, 0.087 mmol) was subjected to DMDO oxidation at
−50 °C for 12 h to produce α-epoxyglucal (20:1, α/β) in quantitative
yield followed by DTC ring opening as previously described. The
crude glycosyl DTC donor was subjected to CuOTf-mediated
glycosylation with 3,4-di-O-benzyl glucal 22 (42 mg, 0.13 mmol) as
3,4,6-Tri-O-benzyl-2-O-triethylsilyl-β-D-glucopyranosyl 1-di-
ethyldithiocarbamate (29). Glycosyl DTC 2 (116 mg, 0.2 mmol)
and imidazole (48 mg, 0.7 mmol) were disolved in THF (2 mL),
cooled to 0 °C under argon, and treated with TESCl (170 μL, 1
mmol). The reaction mixture was stirred at room temperature for 12
h, quenched at 0 °C with saturated NaHCO3 (10 mL), and extracted
with EtOAc (3 × 20 mL). The combined organic extracts were washed
with brine (10 mL), dried over Na2SO4, and concentrated under
reduced pressure. After workup, the yellow syrup was purified by silica
gel chromatography (neutralized with 1% Et3N) using a 20−50%
EtOAc in hexanes gradient with 1% Et3N to afford 2-O-triethylsilyl
1
glycosyl DTC 29 as a colorless syrup (115 mg, 83%). H NMR (500
MHz, C6D6): δ 7.35 (d, 2H, J = 7.5 Hz), 7.23 (d, 2H, J = 7.5 Hz),
7.20−7.02 (m, 11H), 6.22 (d, 1H, J = 10.1 Hz), 5.01 (d, 1H, J = 11.8
2622
dx.doi.org/10.1021/jo500032k | J. Org. Chem. 2014, 79, 2611−2624